Business / Finance

RSS

Vertice Pharma closes previously announced acquisition of VistaPharm

Vertice Pharma, a specialty pharmaceuticals company focused on improving patients' health, today announced it closed on the previously announced acquisition of VistaPharm, a specialized generics manufacturer of liquid and unit dosage pain medications for the hospital market, retail pharmacy and outpatient clinics. Terms of the transaction were not disclosed.

22 Dec 2015

Nuvo reacquires development and marketing rights for Pliaglis

Nuvo Research Inc., a life sciences company with growing revenues and a diverse portfolio of topical products, today announced it has reacquired Pliaglis development and marketing rights for the U.S., Canada and Mexico.

22 Dec 2015

Aquinnah secures $5 million private equity investment from Takeda

Aquinnah Pharmaceuticals announced today that it has received a $5 Million investment from Takeda Pharmaceutical Company, Limited, in it's first private equity financing. The company has assembled a world-class team of drug developers and an exceptional Scientific Advisory Board in the fields of Amyotrophic Lateral Sclerosis (ALS), protein and RNA regulation, and neurodegenerative diseases.

21 Dec 2015

Halozyme Therapeutics, Lilly sign global collaboration and license agreement

Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE platform.

21 Dec 2015

Anytime Fitness acquires PumpOne

Anticipating the needs and preferences of current and future gym members, Anytime Fitness announced today that it has purchased PumpOne – a leading mobile personal training services provider featuring the world's largest exercise image and video library.

21 Dec 2015

SciClone plans to pursue development of SGX942 in the Greater China market

SciClone Pharmaceuticals, Inc. today announced plans to pursue development and registration of SGX942 in the Greater China market, for the treatment of oral mucositis.

21 Dec 2015

Samsung BioLogics celebrates groundbreaking of new biopharmaceutical manufacturing plant in Korea

Samsung BioLogics today celebrated the groundbreaking of its third plant in Incheon Free Economic Zone, Songdo, Korea. Joining the event were Samsung Electronics Vice Chairman Jay Y. Lee, Samsung BioLogics President & CEO Dr. TH Kim and over 500 attendees.

21 Dec 2015

Univercells awarded grant to reduce cost of vaccine manufacturing in the Walloon region

Univercells SA, a company that designs single-use cost-efficient bioprocess solutions for the next generation of biomanufacturing, today announces that it has received a grant from the Walloon region.

21 Dec 2015

Variant signs worldwide exclusive license and development agreement with L&F Research

Variant Pharmaceuticals, Inc., an emerging pharmaceutical company focusing on rare diseases and other specialty conditions with limited or sub-optimal therapeutic options, announced today a worldwide exclusive license and development agreement with L&F Research LLC to advance development of Variant's lead product, VAR 200.

20 Dec 2015

GSI Group purchases SkyeTek assets for $2.6 million

GSI Group Inc., a global leader and supplier of laser, precision motion, and vision technologies to original equipment manufacturers ("OEM") in the medical and advanced industrial markets, today announced it has acquired the assets of SkyeTek, a Denver, Colorado-based provider of embedded and standalone RFID Solutions for medical OEM's for $2.6 million in cash, subject to customary working capital adjustments.

20 Dec 2015

Janssen collaborates with Bavarian Nordic to develop, commercialize vaccine for chronic HPV infections

Janssen Pharmaceuticals, Inc. announced today that the company has entered into a definitive collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN technology, jointly with Janssen's own AdVac® technology, in the development and commercialization of a heterologous prime-boost vaccine for the treatment of Human Papillomavirus (HPV) chronic infections which can lead to cancer.

20 Dec 2015

ALPHAEON announces acquisition of Rocol SA

ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced its acquisition of Rocol SA, a leader in the commercialization of medical equipment across Latin America. Terms of the acquisition were not disclosed.

18 Dec 2015

MPP signs licensing agreement with AbbVie to address future demands for HIV treatment in Africa

The Medicines Patent Pool today announced a new licensing agreement with AbbVie, a global biopharmaceutical company, that seeks to address future demands for HIV treatment Lopinavir/Ritonavir (LPV/r) in South Africa and across Africa. The agreement has been reached in particular to help ensure sustainability of long-term supply of LPV/r, the most widely used second-line HIV treatment in South Africa and across Africa.

18 Dec 2015

Perrigo to acquire generic Retin-A portfolio from Matawan Pharmaceuticals

Perrigo Company plc announced today that it will acquire a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals, LLC. Perrigo was the authorized generic distributor of these products from 2005 to 2013 before the agreement was terminated.

17 Dec 2015

ChemicalInfo partners with e-samples to accelerate sample ordering process for CIS Subscribers

ChemicalInfo, providers of the most comprehensive online databases for chemical and pharmaceutical companies and those who do business with them, announces partnership with e-samples, a comprehensive database offering integrated solutions for samples and development product supply chain processes.

17 Dec 2015

ALPHAEON completes acquisition of LENSAR

ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced it has closed on its acquisition of LENSAR, Inc., a leading global developer and manufacturer of Femtosecond Lasers Systems (FLS), through a wholly owned subsidiary. Terms of the acquisition were not disclosed.

17 Dec 2015

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

WuXi AppTec, a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that it has formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca.

16 Dec 2015

CytoSorbents partners with Hoang Long Pharma to bring CytoSorb to Vietnam

CytoSorbents Corporation, a leader in critical care immunotherapy commercializing its CytoSorb extracorporeal cytokine adsorber to control deadly inflammation using blood purification, today announced an exclusive multi-year distribution agreement with Hoang Long Pharma, a medical distributor in Vietnam specializing in the distribution of innovative pharmaceuticals, biologics, and devices to treat patients suffering from critical illnesses, immunologic disorders and deficiencies, and infections.

15 Dec 2015

ALPHAEON agrees to bring Zelegent's office-based Elevoplasty technology to sleep specialists

ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, and Zelegent, Inc. jointly announced today that the two companies have entered into an exclusive worldwide agreement to bring Zelegent's office-based Elevoplasty technology to board certified sleep specialists.

15 Dec 2015

Honeywell acquires Sigma-Aldrich's laboratory research chemicals business

Honeywell today announced that it has completed the acquisition of the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich, broadening Honeywell's offerings for high-purity solutions for drug discovery, medical diagnostic testing and other laboratory applications.

15 Dec 2015

Business / Finance

Vertice Pharma closes previously announced acquisition of VistaPharm

Nuvo reacquires development and marketing rights for Pliaglis

Aquinnah secures $5 million private equity investment from Takeda

Halozyme Therapeutics, Lilly sign global collaboration and license agreement

Anytime Fitness acquires PumpOne

SciClone plans to pursue development of SGX942 in the Greater China market

Samsung BioLogics celebrates groundbreaking of new biopharmaceutical manufacturing plant in Korea

Univercells awarded grant to reduce cost of vaccine manufacturing in the Walloon region

Variant signs worldwide exclusive license and development agreement with L&F Research

GSI Group purchases SkyeTek assets for $2.6 million

Janssen collaborates with Bavarian Nordic to develop, commercialize vaccine for chronic HPV infections

ALPHAEON announces acquisition of Rocol SA

MPP signs licensing agreement with AbbVie to address future demands for HIV treatment in Africa

Perrigo to acquire generic Retin-A portfolio from Matawan Pharmaceuticals

ChemicalInfo partners with e-samples to accelerate sample ordering process for CIS Subscribers

ALPHAEON completes acquisition of LENSAR

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

CytoSorbents partners with Hoang Long Pharma to bring CytoSorb to Vietnam

ALPHAEON agrees to bring Zelegent's office-based Elevoplasty technology to sleep specialists

Honeywell acquires Sigma-Aldrich's laboratory research chemicals business

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News